$37.5M SIF investment brings BioVectra expansion project to $144.6M

Mark Mann
March 5, 2019

Charlottetown, PEI-based pharmaceutical manufacturer BioVectra Inc. announced a five-year, $144.6 million project to support its active pharmaceutical ingredients (APIs) production capacity and expand its biologics capabilities, including a $37.5 million contribution through the federal government's Strategic Innovation Fund. The project is anticipated to maintain 300 high-skilled, full-time jobs in Atlantic Canada and create 150 more, as well as providing over 25 students with on-the-job training and internship opportunities annually. BioVectra is a Contract Development and Manufacturing Organization (CDMO) serving most of the top 20 biopharmaceutical companies in the world. The company has invested approximately $25 million per year in expansions and technologies since 2015.

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.